Grand Pharmaceutical Group Ltd (512.HK) stock: key figures, P/E, revenue and dividend
Health Care · Hong Kong · ISIN BMG210A71016
Grand Pharmaceutical Group Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 11.64 bn HKD | 12.28 bn HKD |
| Gross profit | 6.74 bn HKD | 6.78 bn HKD |
| EBIT | 2.35 bn HKD | 1.20 bn HKD |
| Net income | 2.47 bn HKD | 1.24 bn HKD |
| Diluted EPS – continuing operations | 0.70 HKD | 0.35 HKD |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Grand Pharmaceutical Group Ltd
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine, and health food products. The company has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company has a strategic partnership with the University of Hong Kong for the research and development of drugs in the field of anti-infection and the industrialization of the research results. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. The company was incorporated in 1995 and is based in Central, Hong Kong.
More stocks
- Shenzhen Microgate Technology Co Ltd (300319.SZ)
- Chorus Ltd (CNU.AX)
- Xinhuanet Co Ltd (603888.SS)
- GORMAN RUPP CO (GRC)
- SMA Solar Technology (S92.DE)
- LEMAITRE VASCULAR INC (LMAT)
- Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707.SS)
- Robertet SA (RBT.PA)
- Zhejiang Kaishan Compressor (300257.SZ)
- Sineng Electric Co Ltd (300827.SZ)
- Guangzhou Kingmed Diagnostics Group Co Ltd (603882.SS)
- Burckhardt Compression Holding AG (BCHN.SW)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.